The development of a good clinical research database is the epitome of valid scientific data collection and management. Good scientific data starts with an unbiased state of mind or a… read more →
The importance of biomarkers/genetic markers cannot be overstated. Biomarkers are one of the most integral part of clinical research and science. In a nutshell, biomarkers are the objective physical or… read more →
The reality and unfortunate idealism is that there is no perfect systematic and legal loopholes reformation in the patient’s health information privacy globally. Health information privacy is a very important… read more →
Conducting clinical research studies, and selecting appropriate subjects within the inclusion criteria is the key to a successful ethical scientific study (Dombey, Markel, & Derenzo, 2012). In any clinical trial,… read more →
In discussing risks and benefits, the institutional review board (IRB) often discusses what makes incentives coercive or non-coercive. However, evaluating whether or not an incentive is coercive is a case… read more →
The main objective of risk management and minimization assessment is tailored in protecting subject’s well-being, welfare and privacy, in clinical studies. Thus, it is important to understand that investigational medicinal… read more →
The purpose of any scientific research is to make predictions, hypothesize, ask questions and derive a deductive answer to a given question. Preclinical studies in animal employ pharmacokinetics, pharmacodynamics and… read more →
Trans-fats are generally known to increase the risk of cardiovascular heart disease. Consumption of trans-fat elevates the level of low density lipoprotein (LDL) (“bad cholesterol”) and consequently lowers the level… read more →
There are many differences between clinical protocols designed for new and unapproved medicinal product’s approval process and protocols designed primarily to increase scientific knowledge. Therefore, addressing the FINER acronym; Feasible,… read more →
Recent Comments